Effect of prenatal supplementation with Vitamin D on asthma or recurrent wheezing in offspring by age 3 years: The VDAART randomized clinical trial

JAMA - Journal of the American Medical Association

Volumn 315, Issue 4, 2016, Pages 362-370

  Litonjua, Augusto A ^a,b   Carey, Vincent J ^a,b   Laranjo, Nancy ^a   Harshfield, Benjamin J ^a   McElrath, Thomas F ^a,b   O'Connor, George T ^c   Sandel, Megan ^d   Iverson, Ronald E ^d   Lee Paritz, Aviva ^d   Strunk, Robert C ^e,f   Bacharier, Leonard B ^e,f   Macones, George A ^e   Zeiger, Robert S ^g   Schatz, Michael ^g   Hollis, Bruce W ^h   Hornsby, Eve ⁱ   Hawrylowicz, Catherine ⁱ   Wu, Ann Chen ^b,j   Weiss, Scott T ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d BOSTON MEDICAL CENTER   (United States)

^e WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f ST LOUIS CHILDREN S HOSPITAL   (United States)

^g KAISER PERMANENTE   (United States)

^h MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

ⁱ GUY S HOSPITAL   (United Kingdom)

^j HARVARD PILGRIM HEALTH CARE INSTITUTE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

25-HYDROXYVITAMIN D; ADVERSE DRUG REACTION; COLECALCIFEROL; DRUG ADMINISTRATION; PLACEBO; VITAMIN; VITAMIN D;

ABNORMAL RESPIRATORY SOUND; ADULT; ANALOGS AND DERIVATIVES; ARTICLE; ASTHMA; BLOOD; CHEMISTRY; CHILD; CHILDHOOD; CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG SAFETY; EPIDEMIOLOGY; FEMALE; FETUS BLOOD; FOLLOW UP; GESTATION PERIOD; HUMAN; HYPERCALCEMIA; INFANT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PREGNANCY; PREGNANT WOMAN; PRESCHOOL CHILD; PREVENTION; PRIORITY JOURNAL; PROGENY; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; THIRD TRIMESTER PREGNANCY; UNITED STATES; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION; WHEEZING; YOUNG ADULT;

ADMINISTRATION AND DOSAGE; ADULT; ADVERSE EFFECTS; ANALOGS AND DERIVATIVES; ASTHMA; BLOOD; CHEMISTRY; CHILD, PRESCHOOL; CHOLECALCIFEROL; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; EPIDEMIOLOGY; FEMALE; FETAL BLOOD; HUMANS; MALE; PREGNANCY; PREGNANCY TRIMESTER, THIRD; PREVENTION AND CONTROL; RECURRENCE; RESPIRATORY SOUNDS; VITAMIN D; VITAMIN D DEFICIENCY; VITAMINS; YOUNG ADULT;

EID: 84964282735     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2015.18589     Document Type: Article

References (28)

1. Morgan WJ, Stern DA, Sherrill DL, et al. Outcome of asthma and wheezing in the first 6 years of life: follow-up through adolescence. Am J Respir Crit Care Med. 2005;172(10):1253-1258.
2. Strachan D, Gerritsen J. Long-term outcome of early childhood wheezing: population data. Eur Respir J Suppl. 1996;21:42s-47s.
3. Ginde AA, Sullivan AF, Mansbach JM, Camargo CA Jr. Vitamin D insufficiency in pregnant and nonpregnant women of childbearing age in the United States. Am J Obstet gynecol. 2010;202(5): 436e1-436e8.
4. Zosky GR, Berry LJ, Elliot JG, James AL, Gorman S, Hart PH. Vitamin D deficiency causes deficits in lung function and alters lung structure. Am J Respir Crit Care Med. 2011;183(10):1336-1343.
5. Ferreira GB, Gysemans CA, Demengeot J, et al. 1, 25-Dihydroxyvitamin D3 promotes tolerogenic dendritic cells with functional migratory properties in NOD mice. J Immunol. 2014;192(9):4210-4220.
6. Xystrakis E, Kusumakar S, Boswell S, et al. Reversing the defective induction of IL-10-secreting regulatory T cells in glucocorticoid-resistant asthma patients. J Clin Invest. 2006;116(1):146-155.
7. Penna G, Amuchastegui S, Giarratana N, et al. 1, 25-Dihydroxyvitamin D3 selectively modulates tolerogenic properties inmyeloid but not plasmacytoid dendritic cells. J Immunol. 2007;178 (1):145-153.
8. YurtM, Liu J, Sakurai R, et al. Vitamin D supplementation blocks pulmonary structural and functional changes in a rat model of perinatal vitamin D deficiency. Am J Physiol Lung Cell Mol Physiol. 2014;307(11):L859-L867.
9. Litonjua AA, Lange NE, Carey VJ, et al. The Vitamin D Antenatal Asthma Reduction Trial (VDAART): rationale, design, and methods of a randomized, controlled trial of vitamin D supplementation in pregnancy for the primary prevention of asthma and allergies in children. Contemp Clin Trials. 2014;38(1):37-50.
10. Dawson-Hughes B, Heaney RP, HolickMF, Lips P, Meunier PJ, Vieth R. Estimates of optimal vitamin D status. Osteoporos Int. 2005;16(7):713-716.
11. Ross AC, Manson JE, Abrams SA, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab. 2011;96(1):53-58.
12. Ersfeld DL, Rao DS, Body JJ, et al. Analytical and clinical validation of the 25 OH vitamin D assay for the LIAISON automated analyzer. Clin Biochem. 2004;37(10):867-874.
13. Grebe SK, Singh RJ. LC-MS/MS in the clinical laboratory-where to from here? Clin Biochem Rev. 2011;32(1):5-31.
14. Litonjua AA, Weiss ST. Is vitamin D deficiency to blame for the asthma epidemic? J Allergy Clin Immunol. 2007;120(5):1031-1035.
15. Gern JE, Visness CM, Gergen PJ, et al. The Urban Environment and Childhood Asthma (URECA) birth cohort study: design, methods, and study population. BMC Pulm Med. 2009;9:17.
16. Oken E, Baccarelli AA, Gold DR, et al. Cohort profile: project viva. Int J Epidemiol. 2015;44 (1):37-48.
17. Sun J. A non-parametric test for interval-censored failure time data with application to AIDS studies. Stat Med. 1996;15(13):1387-1395.
18. Fay MP, Shaw PA. Exact and asymptotic weighted logrank tests for interval censored data: the interval R package. J Stat Softw. 2010;36(2):1-33.
19. Miller RG Jr. Survival Analysis. 2nd ed. Hoboken, NJ: John Wiley & Sons; 2011.
20. Venables WN, Ripley BD. Modern Applied Statisticswith S-PLUS. 3rd ed. New York, NY: Springer; 1999.
21. Dotterud CK, Storrø O, Simpson MR, Johnsen R, Øien T. The impact of pre- and postnatal exposures on allergy related diseases in childhood: a controlled multicentre intervention study in primary health care. BMC Public Health. 2013;13:123.
22. Stevens CA, Turner D, Kuehni CE, Couriel JM, Silverman M. The economic impact of preschool asthma and wheeze. Eur Respir J. 2003;21(6): 1000-1006.
23. Martinez FD, Wright AL, Taussig LM, Holberg CJ, Halonen M, MorganWJ; The Group Health Medical Associates. Asthma and wheezing in the first six years of life. N Engl J Med. 1995;332(3):133-138.
24. Bacharier LB, Guilbert TW. Diagnosis and management of early asthma in preschool-aged children. J Allergy Clin Immunol. 2012;130(2):287-296.
25. Ducharme FM, Tse SM, Chauhan B. Diagnosis, management, and prognosis of preschool wheeze. Lancet. 2014;383(9928):1593-1604.
26. Braig S, Brandt S, Wabitsch M, et al. Age-specific influence of wheezing phenotypes on pre-adolescent and adolescent health-related quality of life. Pediatr Allergy Immunol. 2014;25(8): 781-787.
27. Edwards CA, Osman LM, Godden DJ, Douglas JG. Wheezy bronchitis in childhood: a distinct clinical entity with lifelong significance? Chest. 2003;124(1):18-24.
28. Schittny J, Burri P. Development and growth of the lung. In: Fishman A, Elias J, Fishman J, Grippi M, Senior R, Pack A, eds. Fishman's Pulmonary Diseases and Disorders.Vol 1. NewYork, NY: McGraw-Hill Professional; 2008:91-114.